Literature DB >> 2031995

Efficiency of different criteria for selecting pharmacokinetic multiexponential equations.

B P Imbimbo1, P Martinelli, M Rocchetti, G Ferrari, G Bassotti, E Imbimbo.   

Abstract

Several statistical and empirical approaches have been proposed to select the multiexponential equation that best describes the time course of the plasma concentration of a drug. Recently, a new criterion (Ip) has been proposed according to which the model that best interprets a set of experimental data points is the one with the smallest area between the approximate confidence limits of estimated plasma concentration. We used large Montecarlo simulations to compare the ability of different selection criteria to select the correct model from data generated with an independent, normally distributed random error. The new criterion (Ip), Akaike's information criterion, the Schwartz test, and the F ratio test were studied. In this situation, the correct model was known and the performances of different selecting methods were assessed by examining their sensitivity to the number of exponential terms, the number of data points, and the size of the exponents in the true model. Mono-, bi-, and triexponential equations were studied. Overall mean percentages of right identification were 98.1 per cent for the new index, 82.8 per cent for Akaike's information criterion, 89.5 per cent for the Schwartz test, and 97.7 per cent for the F ratio test. The Akaike and Schwartz tests were not as efficient as the other tests with few (8-10) data points. The Ip and the F test raise the percentages of right identification of the model when the hybrid elimination rate macroconstants differ by at least a factor of four.(ABSTRACT TRUNCATED AT 250 WORDS)

Mesh:

Year:  1991        PMID: 2031995     DOI: 10.1002/bdd.2510120207

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  10 in total

1.  Use of drug kinetics in dermis to predict in vivo blood concentration after topical application.

Authors:  X Gao; M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

2.  Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection.

Authors:  T M Ludden; S L Beal; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1994-10

3.  Statistics or pharmacokinetics?

Authors:  V K Piotrovskij
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

4.  Extensive absorption of 2',3'-dideoxyinosine by intratracheal administration in rats.

Authors:  X Gao; M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

5.  Absorption of 2',3'-dideoxyinosine from lower gastrointestinal tract in rats and kinetic evidence of different absorption rates in colon and rectum.

Authors:  S L Bramer; M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

6.  Penetration kinetics of 2',3'-dideoxyinosine in dermis is described by the distributed model.

Authors:  E Gupta; M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

7.  Interaction between succinylcholine and cimetidine in rats.

Authors:  Y Mishra; I Ramzan
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

8.  Absorption and in vivo dissolution of hydroxycholoroquine in fed subjects assessed using deconvolution techniques.

Authors:  A J McLachlan; S E Tett; D J Cutler; R O Day
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

9.  Individual and population pharmacokinetic compartment analysis: a graphic procedure for quantification of predictive performance.

Authors:  Staffan Eksborg
Journal:  J Drug Assess       Date:  2013-09-03

10.  Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of baclofen in mice.

Authors:  Graciela N Balerio; Modesto C Rubio
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jul-Sep       Impact factor: 2.569

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.